oxatomide has been researched along with Urticaria in 11 studies
oxatomide: structure; an anti-allergic & an anti-asthmatic
oxatomide : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one substituted by a 3-[4-(diphenylmethyl)piperazin-1-yl]propyl group at position 1. It is an anti-allergic drug.
Urticaria: A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.
Excerpt | Relevance | Reference |
---|---|---|
"We compared the efficacy and tolerability of cetirizine in patients with idiopathic chronic urticaria to the more widely used antihistamine, oxatomide." | 9.09 | Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. ( Barberio, G; Corrias, A; Grimaldi, I; La Rosa, M; Leonardi, S; Marchese, G; Oggiano, N, 2001) |
"A new type of antiallergic drug, oxatomide (60 mg daily), was compared with the antihistaminic, mequitazine (10 mg daily), in a 5-week double-blind randomized study involving 26 patients with chronic urticaria." | 9.05 | Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. ( Broux, R; Demaubeuge, J; Tennstedt, D, 1982) |
"Oxatomide was evaluated in a double-blind study of 35 patients with chronic urticaria." | 9.05 | Oxatomide in the treatment of chronic urticaria. A double-blind placebo-controlled trial. ( Campaert, H; Mertens, RL; Morias, J; Peremans, W, 1981) |
"A double-blind trial comparing a new antihistaminic agent (oxatomide) with clemastine was carried out in 30 patients with chronic urticaria." | 9.05 | Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study. ( Beck, HI; Cramers, M; Herlin, T; Søndergaard, I; Zachariae, H, 1985) |
"Four patients suffering from cold urticaria were treated with ketotifen and oxatomide for one week each." | 7.66 | [Effect of ketotifen and oxatomide on histamine liberation due to exposure in cold urticaria]. ( Sauer, RR; Steigleder, GK, 1983) |
"Oxatomide (Tinset) is a new, powerful, antiallergic agent." | 6.67 | [Chronic urticaria: role of oxatomide]. ( Mestre-Deharo, C; Sayag, J, 1990) |
"We compared the efficacy and tolerability of cetirizine in patients with idiopathic chronic urticaria to the more widely used antihistamine, oxatomide." | 5.09 | Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children. ( Barberio, G; Corrias, A; Grimaldi, I; La Rosa, M; Leonardi, S; Marchese, G; Oggiano, N, 2001) |
"A new type of antiallergic drug, oxatomide (60 mg daily), was compared with the antihistaminic, mequitazine (10 mg daily), in a 5-week double-blind randomized study involving 26 patients with chronic urticaria." | 5.05 | Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine. ( Broux, R; Demaubeuge, J; Tennstedt, D, 1982) |
"Oxatomide was evaluated in a double-blind study of 35 patients with chronic urticaria." | 5.05 | Oxatomide in the treatment of chronic urticaria. A double-blind placebo-controlled trial. ( Campaert, H; Mertens, RL; Morias, J; Peremans, W, 1981) |
"A double-blind trial comparing a new antihistaminic agent (oxatomide) with clemastine was carried out in 30 patients with chronic urticaria." | 5.05 | Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study. ( Beck, HI; Cramers, M; Herlin, T; Søndergaard, I; Zachariae, H, 1985) |
"Four patients suffering from cold urticaria were treated with ketotifen and oxatomide for one week each." | 3.66 | [Effect of ketotifen and oxatomide on histamine liberation due to exposure in cold urticaria]. ( Sauer, RR; Steigleder, GK, 1983) |
"Oxatomide (Tinset) is a new, powerful, antiallergic agent." | 2.67 | [Chronic urticaria: role of oxatomide]. ( Mestre-Deharo, C; Sayag, J, 1990) |
"Oxatomide is an orally active H1-histamine receptor antagonist which, as appears to occur with some other antihistamines, also inhibits mast cell degranulation." | 2.37 | Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy. ( Avery, GS; Brogden, RN; Heel, RC; Richards, DM; Speight, TM, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (54.55) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ujiie, H | 1 |
Shimizu, T | 1 |
Natsuga, K | 1 |
Arita, K | 1 |
Tomizawa, K | 1 |
Shimizu, H | 1 |
Demaubeuge, J | 1 |
Tennstedt, D | 1 |
Broux, R | 1 |
Sauer, RR | 1 |
Steigleder, GK | 1 |
Richards, DM | 1 |
Brogden, RN | 1 |
Heel, RC | 1 |
Speight, TM | 1 |
Avery, GS | 1 |
Peremans, W | 1 |
Mertens, RL | 1 |
Morias, J | 1 |
Campaert, H | 1 |
La Rosa, M | 1 |
Leonardi, S | 1 |
Marchese, G | 1 |
Corrias, A | 1 |
Barberio, G | 1 |
Oggiano, N | 1 |
Grimaldi, I | 1 |
Pacor, ML | 1 |
Peroli, P | 1 |
Favari, F | 1 |
Lunardi, C | 1 |
Locci, F | 1 |
Del Giacco, GS | 1 |
Mestre-Deharo, C | 1 |
Sayag, J | 1 |
Beck, HI | 1 |
Cramers, M | 1 |
Herlin, T | 1 |
Søndergaard, I | 1 |
Zachariae, H | 1 |
Pigatto, PD | 1 |
Nicora, M | 1 |
Altomare, GF | 1 |
Morelli, M | 1 |
Finzi, AF | 1 |
1 review available for oxatomide and Urticaria
Article | Year |
---|---|
Oxatomide. A review of its pharmacodynamic properties and therapeutic efficacy.
Topics: Animals; Asthma; Basophils; Histamine H1 Antagonists; Histamine Release; Humans; Hypersensitivity; I | 1984 |
7 trials available for oxatomide and Urticaria
Article | Year |
---|---|
Does mast cell protection plus mediator antagonism surpass the effect of a classic antihistaminic in the treatment of chronic urticaria? A double-blind comparison of oxatomide and mequitazine.
Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Female; Histamine H1 Antagonists; Hum | 1982 |
Oxatomide in the treatment of chronic urticaria. A double-blind placebo-controlled trial.
Topics: Adolescent; Adult; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; M | 1981 |
Double-blind multicenter study on the efficacy and tolerability of cetirizine compared with oxatomide in chronic idiopathic urticaria in preschool children.
Topics: Anti-Allergic Agents; Cetirizine; Child, Preschool; Chronic Disease; Double-Blind Method; Drug Toler | 2001 |
Controlled study of oxatomide vs disodium chromoglycate for treating adverse reactions to food.
Topics: Adolescent; Adult; Aged; Cromolyn Sodium; Double-Blind Method; Eczema; Female; Food Hypersensitivity | 1992 |
Treatment of chronic idiopathic urticaria with topical preparations: controlled study of oxatomide gel versus dechlorpheniramine cream.
Topics: Administration, Topical; Adult; Aged; Erythema; Female; Gels; Histamine H1 Antagonists; Humans; Male | 1991 |
[Chronic urticaria: role of oxatomide].
Topics: Chronic Disease; Double-Blind Method; Histamine H1 Antagonists; Humans; Piperazines; Single-Blind Me | 1990 |
Comparison of oxatomide and clemastine in the treatment of chronic urticaria. A double blind study.
Topics: Adolescent; Adult; Aged; Chromatography, High Pressure Liquid; Clemastine; Clinical Trials as Topic; | 1985 |
3 other studies available for oxatomide and Urticaria
Article | Year |
---|---|
Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
Topics: Adult; Butylscopolammonium Bromide; Drug Therapy, Combination; Exercise; Famotidine; Histamine H1 An | 2006 |
[Effect of ketotifen and oxatomide on histamine liberation due to exposure in cold urticaria].
Topics: Adult; Cold Temperature; Female; Histamine H1 Antagonists; Histamine Release; Humans; Ketotifen; Mal | 1983 |
[Oxatomide in the treatment of chronic urticaria: evaluation of its effectiveness and tolerance].
Topics: Adolescent; Adult; Aged; Chronic Disease; Double-Blind Method; Drug Evaluation; Female; Histamine H1 | 1987 |